NanoCor Therapeutics

NanoCor Therapeutics is a biotechnology company developing cardiovascular gene therapies, including the investigational heart-failure candidate Carfostin. Established in 2006 in Chapel Hill, North Carolina, the company is now identified in scientific disclosures as a subsidiary of AskBio. No current standalone corporate website or commercial approval for Carfostin is verified.